These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 27072244)
21. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy. Chen CC; Wang L; Lin JC; Jan JS J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974 [TBL] [Abstract][Full Text] [Related]
22. The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancer. Tomita N; Kodaira T; Hida T; Tachibana H; Nakamura T; Nakahara R; Inokuchi H Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1121-6. PubMed ID: 19665321 [TBL] [Abstract][Full Text] [Related]
23. [Clinical outcomes and prognostic factors in limited-stage small cell lung cancer: a single institution experience]. Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):223-6. PubMed ID: 25975794 [TBL] [Abstract][Full Text] [Related]
24. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy. Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828 [TBL] [Abstract][Full Text] [Related]
25. Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score. Kim TG; Pyo H; Ahn YC; Noh JM; Oh D J Radiat Res; 2019 Oct; 60(5):630-638. PubMed ID: 31165148 [TBL] [Abstract][Full Text] [Related]
26. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation. Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031 [TBL] [Abstract][Full Text] [Related]
27. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients. Okamoto K; Okamoto I; Takezawa K; Tachibana I; Fukuoka M; Nishimura Y; Nakagawa K Jpn J Clin Oncol; 2010 Jan; 40(1):54-9. PubMed ID: 19837690 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Patel S; Macdonald OK; Suntharalingam M Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355 [TBL] [Abstract][Full Text] [Related]
29. Association between anemia arising during therapy and outcomes of chemoradiation for limited small-cell lung cancer. Laurie SA; Jeyabalan N; Nicholas G; MacRae R; Dahrouge S J Thorac Oncol; 2006 Feb; 1(2):146-51. PubMed ID: 17409844 [TBL] [Abstract][Full Text] [Related]
30. Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer. Han D; Qin Q; Hao S; Huang W; Wei Y; Zhang Z; Wang Z; Li B Radiat Oncol; 2014 Dec; 9():280. PubMed ID: 25498196 [TBL] [Abstract][Full Text] [Related]
31. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer. Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345 [TBL] [Abstract][Full Text] [Related]
32. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin. Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970 [TBL] [Abstract][Full Text] [Related]
33. Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675 [TBL] [Abstract][Full Text] [Related]
34. The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study. Sohn BS; Lee DH; Kim EK; Yoon DH; Kim HO; Ryu JS; Kim SW; Suh C Onkologie; 2012; 35(7-8):432-8. PubMed ID: 22846975 [TBL] [Abstract][Full Text] [Related]
35. Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer. Han TJ; Kim HJ; Wu HG; Heo DS; Kim YW; Lee SH Jpn J Clin Oncol; 2012 Oct; 42(10):948-54. PubMed ID: 22811409 [TBL] [Abstract][Full Text] [Related]
36. Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study. Xenidis N; Kotsakis A; Kalykaki A; Christophyllakis Ch; Giassas S; Kentepozidis N; Polyzos A; Chelis L; Vardakis N; Vamvakas L; Georgoulias V; Kakolyris S Lung Cancer; 2010 Jun; 68(3):450-4. PubMed ID: 19783319 [TBL] [Abstract][Full Text] [Related]
37. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
38. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute. Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821 [TBL] [Abstract][Full Text] [Related]
39. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens. Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902 [TBL] [Abstract][Full Text] [Related]
40. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation. Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]